The use of black raspberry improved cardiovascular risks in patients with metabolic syndrome during the 12-week follow-up.

– GreenMedInfo Summary

Click here to read the complete article.

Abstract Title:

Black Raspberry Extract Increased Circulating Endothelial Progenitor Cells and Improved Arterial Stiffness in Patients with Metabolic Syndrome: A Randomized Controlled Trial.

Abstract Source:

J Med Food. 2016 Apr ;19(4):346-52. Epub 2016 Feb 18. PMID: 26891216

Abstract Author(s):

Han Saem Jeong, Sohyeon Kim, Soon Jun Hong, Seung Cheol Choi, Ji-Hyun Choi, Jong-Ho Kim, Chi-Yeon Park, Jae Young Cho, Tae-Bum Lee, Ji-Wung Kwon, Hyung Joon Joo, Jae Hyoung Park, Cheol Woong Yu, Do-Sun Lim

Article Affiliation:

Han Saem Jeong

Abstract:

Administration of black raspberry (Rubus occidentalis) is known to improve vascular endothelial function in patients at a high risk for cardiovascular (CV) disease. We investigated short-term effects of black raspberry on circulating endothelial progenitor cells (EPCs) and arterial stiffness in patients with metabolic syndrome. Patients with metabolic syndrome (n = 51) were prospectively randomized into the black raspberry group (n = 26, 750 mg/day) and placebo group (n = 25) during the 12-week follow-up. Central blood pressure, augmentation index, and EPCs, such as CD34/KDR(+), CD34/CD117(+), and CD34/CD133(+), were measured at baseline and at 12-week follow-up. Radial augmentation indexes were significantly decreased in the black raspberry group compared to the placebo group (-5% ± 10% vs. 3% ± 14%, P < .05). CD34/CD133(+) cells at 12-week follow-up were significantly higher in the black raspberry group compared to the placebo group (19 ± 109/μL vs. -28 ± 57/μL, P < .05). Decreases from the baseline in interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) were significantly greater in the black raspberry group compared to the placebo group (-0.5 ± 1.4 pg/mL vs. -0.1 ± 1.1 pg/mL, P < .05 and -5.4 ± 4.5 pg/mL vs. -0.8 ± 4.0 pg/mL, P < .05, respectively). Increases from the baseline in adiponectin levels (2.9 ± 2.1 μg/mL vs. -0.2 ± 2.5 μg/mL, P < .05) were significant in the black raspberry group. The use of black raspberry significantly lowered the augmentation index and increased circulating EPCs, thereby improving CV risks in patients with metabolic syndrome during the 12-week follow-up.

Academic Cite:

Han Saem Jeong, Sohyeon Kim, Soon Jun Hong, Seung Cheol Choi, Ji-Hyun Choi, Jong-Ho Kim, Chi-Yeon Park, Jae Young Cho, Tae-Bum Lee, Ji-Wung Kwon, Hyung Joon Joo, Jae Hyoung Park, Cheol Woong Yu, Do-Sun Lim. Black Raspberry Extract Increased Circulating Endothelial Progenitor Cells and Improved Arterial Stiffness in Patients with Metabolic Syndrome: A Randomized Controlled Trial. J Med Food. 2016 Apr ;19(4):346-52. Epub 2016 Feb 18.

Pubmed-Cite:

Han Saem Jeong, Sohyeon Kim, Soon Jun Hong, Seung Cheol Choi, Ji-Hyun Choi, Jong-Ho Kim, Chi-Yeon Park, Jae Young Cho, Tae-Bum Lee, Ji-Wung Kwon, Hyung Joon Joo, Jae Hyoung Park, Cheol Woong Yu, Do-Sun Lim. Black Raspberry Extract Increased Circulating Endothelial Progenitor Cells and Improved Arterial Stiffness in Patients with Metabolic Syndrome: A Randomized Controlled Trial. J Med Food. 2016 Apr ;19(4):346-52. Epub 2016 Feb 18. PMID: 26891216

GMI-Cite:

Han Saem Jeong, Sohyeon Kim, Soon Jun Hong, Seung Cheol Choi, Ji-Hyun Choi, Jong-Ho Kim, Chi-Yeon Park, Jae Young Cho, Tae-Bum Lee, Ji-Wung Kwon, Hyung Joon Joo, Jae Hyoung Park, Cheol Woong Yu, Do-Sun Lim. Black Raspberry Extract Increased Circulating Endothelial Progenitor Cells and Improved Arterial Stiffness in Patients with Metabolic Syndrome: A Randomized Controlled Trial. J Med Food. 2016 Apr ;19(4):346-52. Epub 2016 Feb 18. PMID: 26891216

Article Published Date : Mar 31, 2016

Study Type : Human Study

Additional Links

Substances : Black Raspberry : CK(114) : AC(33)

Diseases : Cardiovascular Disease: Prevention : CK(3250) : AC(433)Metabolic Diseases : CK(411) : AC(75)

Pharmacological Actions : Anti-Inflammatory Agents : CK(4861) : AC(1630)Interleukin-6 Downregulation : CK(1137) : AC(354)Tumor Necrosis Factor (TNF) Alpha Inhibitor : CK(1823) : AC(669)